VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_18-vv-01317
Package ID: USCOURTS-cofc-1_18-vv-01317
Petitioner: Mark T. Moore
Filed: 2018-08-28
Decided: 2020-10-20
Vaccine: Tdap
Vaccination date: 2017-08-09
Condition: Guillain-Barré syndrome
Outcome: compensated
Award amount USD: 107000

AI-assisted case summary:
Mark T. Moore filed a petition for compensation on August 28, 2018, alleging that the Tdap vaccine he received on August 9, 2017, caused him to develop Guillain-Barré syndrome (GBS). He further alleged that he suffered residual effects from the GBS for more than six months. The respondent, the Secretary of Health and Human Services, denied that the vaccine caused or aggravated Mr. Moore's condition. The parties subsequently reached a joint stipulation, which was filed on September 23, 2020. Special Master Christian J. Moran reviewed the stipulation and found it reasonable, adopting it as the decision of the Court. The stipulation awarded Mr. Moore a lump sum payment of $107,000.00 as compensation for all damages. The decision was issued on October 20, 2020. Petitioner was represented by Summer P. Abel of the Law Offices of Leah V. Durant, PLLC, and respondent was represented by Christine M. Becer of the United States Department of Justice. The public decision does not describe the specific onset of symptoms, diagnostic tests, treatments, or expert witnesses involved in this case.

Theory of causation field:
Petitioner Mark T. Moore alleged that the Tdap vaccine administered on August 9, 2017, caused Guillain-Barré syndrome (GBS), an injury listed on the Vaccine Injury Table. Petitioner further alleged residual effects lasting more than six months. Respondent denied causation. The parties reached a stipulation, adopted by Special Master Christian J. Moran on October 20, 2020, awarding $107,000.00 for all damages. The theory of causation relied upon was that the Tdap vaccine caused GBS, consistent with the Vaccine Injury Table. The public decision does not detail the specific mechanism of injury, expert testimony, or the evidence considered beyond the stipulation.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_18-vv-01317-0
Date issued/filed: 2020-10-20
Pages: 2
Docket text: PUBLIC DECISION (Originally filed: 09/23/2020) regarding 42 DECISION Stipulation/Proffer. Signed by Special Master Christian J. Moran. (Attachments: # (1) Joint Stipulation) (hh) Service on parties made.
--------------------------------------------------------------------------------
Case 1:18-vv-01317-UNJ Document 47 Filed 10/20/20 Page 1 of 2
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
* * * * * * * * * * * * * * * * * * * * *
MARK T. MOORE, *
* No. 18-1317V
Petitioner, * Special Master Christian J. Moran
*
v. * Filed: September 23, 2020
*
SECRETARY OF HEALTH * Stipulation; Tdap vaccine;
AND HUMAN SERVICES, * Guillain-Barré syndrome
* (“GBS”).
*
Respondent. *
* * * * * * * * * * * * * * * * * * * * *
Summer P. Abel, Law Offices of Leah V. Durant, PLLC, Washington, DC, for
Petitioner;
Christine M. Becer, United States Dep’t of Justice, Washington, DC, for
Respondent.
UNPUBLISHED DECISION1
On September 23, 2020, the parties filed a joint stipulation concerning the
petition for compensation filed by Mark T. Moore on August 28, 2018. Petitioner
alleged that the tetanus-diphtheria-acellular pertussis (“Tdap”) vaccine he received
on August 9, 2017, which is contained in the Vaccine Injury Table (the “Table”),
42 C.F.R. §100.3(a), caused him to suffer Guillain-Barré syndrome. Petitioner
further alleges that he suffered the residual effects of this injury for more than six
months. Petitioner represents that there has been no prior award or settlement of a
civil action for damages on his behalf as a result of his condition.
1 The E-Government Act, 44 U.S.C. § 3501 note (2012) (Federal Management and
Promotion of Electronic Government Services), requires that the Court post this decision on its
website. Pursuant to Vaccine Rule 18(b), the parties have 14 days to file a motion proposing
redaction of medical information or other information described in 42 U.S.C. § 300aa-12(d)(4).
Any redactions ordered by the special master will appear in the document posted on the website.

Case 1:18-vv-01317-UNJ Document 47 Filed 10/20/20 Page 2 of 2
Respondent denies that the vaccines either caused or significantly
aggravated petitioner’s alleged injury or any other injury, and denies that
petitioner's current disabilities are the result of a vaccine-related injury.
Nevertheless, the parties agree to the joint stipulation, attached hereto. The
undersigned finds said stipulation reasonable and adopts it as the decision of the
Court in awarding damages, on the terms set forth therein.
Damages awarded in that stipulation include:
A lump sum payment of $107,000.00 in the form of a check payable to
petitioner. This amount represents compensation for all damages that
would be available under 42 U.S.C. § 300aa-15(a).
In the absence of a motion for review filed pursuant to RCFC, Appendix B,
the clerk is directed to enter judgment in case 18-1317V according to this decision
and the attached stipulation.2
IT IS SO ORDERED.
s/Christian J. Moran
Christian J. Moran
Special Master
2 Pursuant to Vaccine Rule 11(a), the parties can expedite entry of judgment by each
party filing a notice renouncing the right to seek review by a United States Court of Federal
Claims judge.
2